All Day

8th Neuropsychiatric Drug Development Summit

Hilton Boston Logan Airport One Hotel Dr, Boston

Industry’s Flagship Forum Capturing Advancements Across Discovery, Preclinical, Translational, Clinical & Regulatory Development of Innovative Neuropsychiatric Therapeutics Uniting 150+ discovery, preclinical, translational, clinical, and regulatory leaders, the 8th Neuropsychiatric Drug Development Summit returns to provide you with an unrivaled opportunity to stay attuned to the latest progress while tackling industry’s most pressing challenges across a wide spectrum of mental health indications. […]

Transdermal and Microneedle Drug Delivery

Hilton London Kensington 179-199 Holland Park Ave, London

Have you considered how microneedle drug delivery systems could revolutionise the future of vaccine and drug administration? This November, join SAE Media’s 4th Annual Transdermal and Microneedle Drug Delivery Conference. Engage with leading drug development and delivery experts in a dynamic, expert-led environment. Connect with forward-thinking innovators to explore cutting-edge case studies, breakthrough vaccine and […]

7th Targeted Radiopharmaceuticals Summit Europe

Mövenpick Hotel Amsterdam City Centre Piet Heinkade 11, Amsterdam

7th Targeted Radiopharmaceuticals Summit Europe 10–12 November 2025 | Amsterdam Translating Novel Radiopharmaceutical Therapies to Transform the Medical Future Now in its seventh year, the Targeted Radiopharmaceuticals Summit Europe returns to Amsterdam to bring together over 200 leaders in radiopharmaceutical therapy development. Designed to establish radiopharmaceuticals as a core pillar of oncology, this event is […]

7th TIL Therapies Summit

The Westin Boston Seaport District 425 Summer Street, Boston

Now in its seventh year, the TIL Therapies Summit returns as the leading event dedicated to advancing tumor-infiltrating lymphocytes (TIL) therapies. Taking place November 11–13, 2025, in Boston (MA), this summit unites global experts across biopharma, academia, clinical practice, and manufacturing to accelerate the development and commercialization of next-generation TIL treatments. Following the first-ever FDA […]